Hsu CH - Search Results

1

Hsu HJ, Hsu CK, Chen TS, Hsu CH. Hsu HJ, et al. Among authors: hsu ch, hsu ck. QJM. 2016 Jan;109(1):67-8. doi: 10.1093/qjmed/hcv165. Epub 2015 Oct 8. QJM. 2016. PMID: 26450988 No abstract available.

2

Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy.

Shao YY, Chen BB, Ou DL, Lin ZZ, Hsu CH, Wang MJ, Cheng AL, Hsu C. Shao YY, et al. Among authors: hsu c, hsu ch. Aliment Pharmacol Ther. 2017 Oct;46(8):722-730. doi: 10.1111/apt.14270. Epub 2017 Aug 17. Aliment Pharmacol Ther. 2017. PMID: 28815645 Clinical Trial.

3

Co-occurrence of second primary malignancy in patients with thyroid cancer.

Hsu CH, Huang CL, Hsu YH, Iqbal U, Nguyen PA, Jian WS. Hsu CH, et al. Among authors: hsu yh. QJM. 2014 Aug;107(8):643-8. doi: 10.1093/qjmed/hcu051. Epub 2014 Mar 11. QJM. 2014. PMID: 24623860

4

Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems.

Shao YY, Lu LC, Lin ZZ, Hsu C, Shen YC, Hsu CH, Cheng AL. Shao YY, et al. Among authors: hsu c, hsu ch. Br J Cancer. 2012 Nov 6;107(10):1672-7. doi: 10.1038/bjc.2012.466. Epub 2012 Oct 11. Br J Cancer. 2012. PMID: 23059748 Free PMC article.

5

Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma.

Hsu CH, Yang TS, Hsu C, Toh HC, Epstein RJ, Hsiao LT, Chen PJ, Lin ZZ, Chao TY, Cheng AL. Hsu CH, et al. Among authors: hsu c. Br J Cancer. 2010 Mar 16;102(6):981-6. doi: 10.1038/sj.bjc.6605580. Epub 2010 Feb 16. Br J Cancer. 2010. PMID: 20160718 Free PMC article. Clinical Trial.

6

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO.

Chen LT, Martinelli E, Cheng AL, Pentheroudakis G, Qin S, Bhattacharyya GS, Ikeda M, Lim HY, Ho GF, Choo SP, Ren Z, Malhotra H, Ueno M, Ryoo BY, Kiang TC, Tai D, Vogel A, Cervantes A, Lu SN, Yen CJ, Huang YH, Chen SC, Hsu C, Shen YC, Tabernero J, Yen Y, Hsu CH, Yoshino T, Douillard JY. Chen LT, et al. Among authors: hsu c, hsu ch. Ann Oncol. 2020 Mar;31(3):334-351. doi: 10.1016/j.annonc.2019.12.001. Epub 2019 Dec 20. Ann Oncol. 2020. PMID: 32067677 Free article.

7

Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/leucovorin for locally advanced or metastatic carcinoma of the biliary tract.

Hsu C, Shen YC, Yang CH, Yeh KH, Lu YS, Hsu CH, Liu HT, Li CC, Chen JS, Wu CY, Cheng AL. Hsu C, et al. Among authors: hsu ch. Br J Cancer. 2004 May 4;90(9):1715-9. doi: 10.1038/sj.bjc.6601796. Br J Cancer. 2004. PMID: 15150619 Free PMC article. Clinical Trial.

8

HHT and gastric telangiectasia.

Lay PL, Huang TY, Hsu CH. Lay PL, et al. Among authors: hsu ch. QJM. 2016 Jan;109(1):59. doi: 10.1093/qjmed/hcv122. Epub 2015 Jul 1. QJM. 2016. PMID: 26135401 No abstract available.

9

Sturge-Weber syndrome.

Ho TH, Yang FC, Lin JC, Hsu CH, Lee JT. Ho TH, et al. Among authors: hsu ch. QJM. 2019 Apr 1;112(4):299. doi: 10.1093/qjmed/hcy246. QJM. 2019. PMID: 30357409 No abstract available.

10

Hemogram-based decision tree for predicting the metabolic syndrome and cardiovascular diseases in the elderly.

Hsu CH, Chen YL, Hsieh CH, Liang YJ, Liu SH, Pei D. Hsu CH, et al. QJM. 2021 Oct 7;114(6):363-373. doi: 10.1093/qjmed/hcaa205. QJM. 2021. PMID: 32573729 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,314 results

Search Page